India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...
India Today on MSN
Weight-loss injections may be behind gallbladder removal. Here's why
Rising use of weight loss injections may be linked to more gallbladder surgeries. Experts urge caution, deeper research and ...
The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...
DCGI approval to Sun Pharma comes amid an ongoing patent dispute with Novo Nordisk in the Delhi High Court. The case relates ...
New Delhi — Chinese and Japanese injection molding machinery makers are planning capacity expansions in India to meet growth in the country's domestic market, particularly with higher-tonnage machines ...
Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in India as ...
Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results